HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Secondary hemophagocytic syndrome due to Peg-interferon administration].

AuthorsJesús Ruiz Ramos
JournalFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (Farm Hosp) Vol. 38 Issue 1 Pg. 73-4 (Jan 01 2014) ISSN: 2171-8695 [Electronic] Spain
Vernacular TitleSíndrome hemafogocítico secundario a la administración de Peg-interferón.
PMID24483865 (Publication Type: Case Reports, Letter)
Chemical References
  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a
Topics
  • Antiviral Agents (adverse effects, therapeutic use)
  • Hepatitis C (complications, drug therapy)
  • Humans
  • Interferon-alpha (adverse effects, therapeutic use)
  • Liver Transplantation
  • Lymphohistiocytosis, Hemophagocytic (chemically induced)
  • Male
  • Middle Aged
  • Polyethylene Glycols (adverse effects, therapeutic use)
  • Recombinant Proteins (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: